Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cytogenetic abnormalities in essential thrombocythemia: Clinical and molecular correlates and prognostic relevance in 809 informative cases.

Blood cancer journal - 17 Mar 2022

Gangat Naseema, Jadoon Yamna, Szuber Natasha, Hanson Curtis A, Wolanskyj-Spinner Alexandra P, Ketterling Rhett P, Pardanani Animesh, Tefferi Ayalew

Abstract excerpt

Cytogenetic studies among 809 consecutive patients with essential thrombocythemia (ET; median age 59 years; 65% females) revealed normal karyotype in 754 (93%), loss of chromosome Y only (-Y) in 16 (2%), and abnormalities other than -Y in 39 (4.8%), the most frequent being sole 20q- (n = 8). At presentation, abnormal karyotype, excluding -Y, was associated with older age (p = 0.04), higher leukocyte count...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Abnormal Karyotype
Share to Chromosome Aberrations

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Prognosis

Share to Thrombocythemia, Essential

Source

Open in PubMed Open full text

Identifiers

PMID: 35301278
DOI: 10.1038/s41408-022-00639-z
PMCID: PMC8931050

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cytogenetic abnormalities in essential thrombocythemia: Clinical and molecular correlates and prognostic relevance in 809 informative cases.PMID 35301278Read ↗

Cytogenetic abnormalities in essential thrombocythemia: prevalence and prognostic significance.Semantic proximity Read ↗

Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients.Semantic proximity Read ↗

Essential thrombocythemia.Semantic proximity Read ↗

The Roles of Genetic and Epigenetic Abnormalities in Essential ThrombocythemiaSemantic proximity Read ↗

One thousand patients with essential thrombocythemia: the Mayo Clinic experience.Semantic proximity Read ↗

Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management.Semantic proximity Read ↗

Essential thrombocythemia: a review of the clinical features, diagnostic challenges, and treatment modalities in the era of molecular discovery.Semantic proximity Read ↗

Assessing the thrombotic risk of patients with essential thrombocythemia in the genomic era.Semantic proximity Read ↗

Cytogenetic studies at diagnosis in polycythemia vera: clinical and JAK2V617F allele burden correlates.Semantic proximity Read ↗

Conventional cytogenetics in myelofibrosis: literature review and discussionSemantic proximity Read ↗

A compendium of cytogenetic abnormalities in myelofibrosis: molecular and phenotypic correlates in 826 patientsSemantic proximity Read ↗

Clinico-hematological profile and thrombotic/hemorrhagic events in 150 chinese patients with essential thrombocythemia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.